Opportunities to “fix” the US healthcare system will continue to accelerate start-up funding and the digital disruption. Accenture research estimates that digital health funding will double in the next three years, growing to $6.5 billion by 2017. The momentum will be sustained as digital health start-ups (and their funding entities) pursue a variety of ways to combine SMACS capabilities into a seamless experience that results in both medical cost savings and improved health outcomes.
In the paper, Accenture research identifies four distinct market segments that have received start-up funding between 2008 and 2013.1
Through 2017, Accenture predicts that stand-out organizations, and their applications, will succeed through the linkage of capabilities across these four segments. Emerging technologies will include clinical applications that meet regulatory approval and solutions with more advanced analytics capabilities, such as quantum computing, for example.
VIEW ARTICLE [PDF]